Biondo Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Biondo Investment Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$4.25M	Sell
2021 Q4	$3.73M	Buy
2021 Q3	$3.84M	Buy
2021 Q2	$4.2M	Buy